These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9922029)

  • 21. Intravenous immune globulin: an alternative therapy in steroid-dependent allergic diseases.
    Gelfand EW; Landwehr LP; Esterl B; Mazer B
    Clin Exp Immunol; 1996 May; 104 Suppl 1():61-6. PubMed ID: 8625546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of atopic dermatitis with a combination of allergen-specific immunotherapy and a histamine-immunoglobulin complex.
    Nahm DH; Lee ES; Park HJ; Kim HA; Choi GS; Jeon SY
    Int Arch Allergy Immunol; 2008; 146(3):235-40. PubMed ID: 18268392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral administration of Lactococcus chungangensis inhibits 2,4-dinitrochlorobenzene-induced atopic-like dermatitis in NC/Nga mice.
    Choi WJ; Konkit M; Kim Y; Kim MK; Kim W
    J Dairy Sci; 2016 Sep; 99(9):6889-6901. PubMed ID: 27289147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tolerogenic antigen-presenting cells successfully inhibit atopic dermatitis-like skin lesion induced by repeated epicutaneous exposure to ovalbumin.
    Katagiri K; Arakawa S; Hatano Y; Fujiwara S
    Arch Dermatol Res; 2008 Nov; 300(10):583-93. PubMed ID: 18528699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sustained exogenous expression of therapeutic levels of IFN-gamma ameliorates atopic dermatitis in NC/Nga mice via Th1 polarization.
    Hattori K; Nishikawa M; Watcharanurak K; Ikoma A; Kabashima K; Toyota H; Takahashi Y; Takahashi R; Watanabe Y; Takakura Y
    J Immunol; 2010 Mar; 184(5):2729-35. PubMed ID: 20107184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Th2 systemic immune milieu enhances cutaneous inflammation in the K14-IL-4-transgenic atopic dermatitis model.
    Reichle ME; Chen L; Lin SX; Chan LS
    J Invest Dermatol; 2011 Mar; 131(3):791-4. PubMed ID: 21191418
    [No Abstract]   [Full Text] [Related]  

  • 27. [Modern technologies for the management of atopic dermatitis in children].
    Smirnova GI
    Vestn Ross Akad Med Nauk; 2008; (12):26-32. PubMed ID: 19186514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lesional expression of interferon-gamma in atopic eczema.
    Grewe M; Gyufko K; Schöpf E; Krutmann J
    Lancet; 1994 Jan; 343(8888):25-6. PubMed ID: 7905045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Commonality of the IL-4/IL-13 pathway in atopic diseases.
    Gandhi NA; Pirozzi G; Graham NMH
    Expert Rev Clin Immunol; 2017 May; 13(5):425-437. PubMed ID: 28277826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of hyperbaric oxygenation in atopic dermatitis.
    Olszański R; Pachut M; Sićko Z; Sztaba-Kania M; Wilkowska A
    Bull Inst Marit Trop Med Gdynia; 1992; 43(1-4):79-82. PubMed ID: 1345603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Staphylococcus aureus modifies the cytokine-induced immunoglobulin synthesis and CD23 expression in patients with atopic dermatitis.
    Neuber K; Stephan U; Fränken J; König W
    Immunology; 1991 Jun; 73(2):197-204. PubMed ID: 1830026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Various immunological indicators in patients with atopic dermatitis during reflexotherapy].
    Shinaev NN; Kochergin NG; Belokrinitskiĭ DV; Rumiantseva EE; Kudriashova NM
    Vestn Dermatol Venerol; 1985 Feb; (2):39-42. PubMed ID: 3873145
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of IGIV in the treatment of atopic dermatitis, urticaria, scleromyxedema, pyoderma gangrenosum, psoriasis, and pretibial myxedema.
    Jolles S; Hughes J
    Int Immunopharmacol; 2006 Apr; 6(4):579-91. PubMed ID: 16504920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amelioration of the progression of an atopic dermatitis-like skin lesion by silk peptide and identification of functional peptides.
    Ikegawa Y; Sato S; Lim G; Hur W; Tanaka K; Komori M; Takenaka S; Taira T
    Biosci Biotechnol Biochem; 2012; 76(3):473-7. PubMed ID: 22451387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-mycotics suppress interleukin-4 and interleukin-5 production in anti-CD3 plus anti-CD28-stimulated T cells from patients with atopic dermatitis.
    Kanda N; Enomoto U; Watanabe S
    J Invest Dermatol; 2001 Dec; 117(6):1635-46. PubMed ID: 11886533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous immunoglobulin to treat severe atopic dermatitis in children: a case series.
    Turner PJ; Kakakios A; Wong LC; Wong M; Campbell DE
    Pediatr Dermatol; 2012; 29(2):177-81. PubMed ID: 22085141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Atopic dermatitis: pathogenesis and treatment--international principle].
    Glinski W
    Pneumonol Alergol Pol; 2002; 70 Suppl 1():39-40. PubMed ID: 12580162
    [No Abstract]   [Full Text] [Related]  

  • 38. [Therapeutic overtures in atopic dermatitis].
    Guilhou JJ
    Rev Prat; 1990 Apr; 40(12):1109-11. PubMed ID: 2345853
    [No Abstract]   [Full Text] [Related]  

  • 39. Ketoconazole suppresses interleukin-4 plus anti-CD40-induced IgE class switching in surface IgE negative B cells from patients with atopic dermatitis.
    Kanda N; Watanabe S
    J Invest Dermatol; 2002 Sep; 119(3):590-9. PubMed ID: 12230500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dichotomic nature of atopic dermatitis reflected by combined analysis of monocyte immunophenotyping and single nucleotide polymorphisms of the interleukin-4/interleukin-13 receptor gene: the dichotomy of extrinsic and intrinsic atopic dermatitis.
    Novak N; Kruse S; Kraft S; Geiger E; Klüken H; Fimmers R; Deichmann KA; Bieber T
    J Invest Dermatol; 2002 Oct; 119(4):870-5. PubMed ID: 12406333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.